RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,392,861 | -28.4% | 805,828 | -19.4% | 1.54% | -12.7% |
| Q2 2023 | $18,700,000 | +16.3% | 1,000,000 | +14.2% | 1.77% | -41.5% |
| Q1 2023 | $16,074,306 | -7.7% | 875,984 | -0.5% | 3.02% | -12.9% |
| Q4 2022 | $17,424,000 | +7.2% | 880,000 | +30.3% | 3.47% | +66.9% |
| Q3 2022 | $16,255,000 | -13.0% | 675,617 | -34.0% | 2.08% | -34.4% |
| Q2 2022 | $18,676,000 | -22.0% | 1,023,321 | -6.0% | 3.17% | +27.0% |
| Q1 2022 | $23,932,000 | -47.8% | 1,088,321 | -12.8% | 2.49% | -52.7% |
| Q4 2021 | $45,851,000 | +28.6% | 1,248,321 | +8.7% | 5.27% | +21.5% |
| Q3 2021 | $35,655,000 | +15.5% | 1,148,321 | +18.3% | 4.34% | +21.3% |
| Q2 2021 | $30,862,000 | +271.7% | 970,821 | +159.6% | 3.58% | +321.7% |
| Q1 2021 | $8,303,000 | +65.8% | 374,021 | +47.5% | 0.85% | +56.5% |
| Q4 2020 | $5,009,000 | – | 253,608 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $35,171,000 | 45.66% |
| KPCB XV Associates, LLC | 1,297,063 | $28,522,000 | 36.91% |
| Ponoi II Management, LLC | 145,401 | $3,197,000 | 7.10% |
| Column Group LLC | 1,402,008 | $30,830,000 | 5.72% |
| Euclidean Capital LLC | 432,900 | $9,519,000 | 5.53% |
| AJU IB Investment Co., Ltd. | 99,503 | $2,188,000 | 3.38% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,088,321 | $23,932,000 | 2.49% |
| Velan Capital Investment Management LP | 110,000 | $2,419,000 | 2.24% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $9,755,000 | 1.46% |
| Perceptive Advisors | 2,799,962 | $61,571,000 | 1.23% |